Oruka Therapeutics, Inc. — SC 13G Filings
40 SC 13G filings on record
This page lists all SC 13G filings submitted to the SEC by Oruka Therapeutics, Inc. (ORKA), sorted by most recent first. Each row links to the full filing on EdgarLookup. Oruka Therapeutics, Inc. has filed 40 SC 13G documents with the SEC since 2008. To view all SEC filings by Oruka Therapeutics, Inc., see the full filings list.
All
10-K
10-K/A
10-K405
10-Q
10-Q/A
144
3
3/A
4
4/A
424B2
424B3
424B4
424B5
425
5
8-A12G
8-K
8-K/A
ARS
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
EFFECT
POS AM
PRE 14A
PRER14A
RW
S-1
S-1/A
S-1MEF
S-3
S-3/A
S-3ASR
S-3MEF
S-4
S-4/A
S-8
S-8 POS
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SC 13G | — | 0000315066-24-002024 | Oct 7, 2024 | — |
| SC 13G | SC 13G | 0001104659-24-054266 | Apr 29, 2024 | — |
| SC 13G | — | 0001013594-24-000372 | Apr 15, 2024 | — |
| SC 13G | JANUS HENDERSON GROUP PLC OWNS 7.4% OF ARCA BIOPHARMA, INC | 0001274173-24-000067 | Apr 11, 2024 | — |
| SC 13G | — | 0000919574-24-002436 | Apr 9, 2024 | — |
| SC 13G | SC 13G | 0001193125-23-232441 | Sep 11, 2023 | — |
| SC 13G | NONE | 0001567619-22-001853 | Jan 27, 2022 | — |
| SC 13G | ACQUISITION OF BENEFICIAL OWNERSHIP | 0001387131-20-005573 | Jun 10, 2020 | — |
| SC 13G | SABBY 13G ABIO 6.01.20 | 0001535610-20-000096 | Jun 1, 2020 | — |
| SC 13G | — | 0001037389-19-000002 | Feb 12, 2019 | — |
| SC 13G | SC 13G | 0001104659-16-096171 | Feb 12, 2016 | — |
| SC 13G | SCHEDULE 13G | 0001193125-15-234989 | Jun 25, 2015 | — |
| SC 13G | SC 13G | 0001144204-15-039125 | Jun 25, 2015 | — |
| SC 13G | SC 13G | 0001136261-13-000433 | Oct 7, 2013 | — |
| SC 13G | SABBY 13G ABIO 06.03.13 | 0001535610-13-000039 | Jun 3, 2013 | — |
| SC 13G | SCHEDULE 13G | 0001193125-12-518039 | Dec 28, 2012 | — |
| SC 13G | SABBY 13G ABIO 8.08.12 | 0001535610-12-000011 | Aug 8, 2012 | — |
| SC 13G | SC 13G | 0000950123-11-040357 | Apr 28, 2011 | — |
| SC 13G | SC 13G | 0000950123-11-040375 | Apr 28, 2011 | — |
| SC 13G | SC 13G | 0000950123-10-013000 | Feb 16, 2010 | — |
| SC 13G | — | 0001325447-10-000005 | Feb 10, 2010 | — |
| SC 13G | — | 0001037389-09-000210 | Feb 13, 2009 | — |
| SC 13G | FILER: ATLAS VENTURE FUND VII, LP - SUBJECT COMPANY: ARCA BIOPHARMA, INC. | 0000950135-09-000847 | Feb 10, 2009 | — |
| SC 13G | SCHEDULE 13G | 0000950134-09-001965 | Feb 5, 2009 | — |
| SC 13G | — | 0001325447-08-000044 | Dec 8, 2008 | — |
| SC 13G | NUVELO, INC. | 0000950135-08-003756 | May 16, 2008 | — |
| SC 13G | SCHEDULE 13G | 0001019056-07-000751 | Aug 13, 2007 | — |
| SC 13G | NUVELO INC 13G | 0000908733-07-000215 | Jan 12, 2007 | — |
| SC 13G | SCHEDULE 13G | 0000932440-06-000170 | Apr 11, 2006 | — |
| SC 13G | — | 0000895345-05-001086 | Nov 14, 2005 | — |
| SC 13G | INITIAL FILING ON SCHEDULE 13G | 0000899140-05-000303 | Mar 18, 2005 | — |
| SC 13G | NUVELO INC. SC 13G | 0000902664-03-000989 | Jul 28, 2003 | — |
| SC 13G | 2000 SCHEDULE 13G - HYSEQ INC | 0000354204-01-000772 | Feb 2, 2001 | — |
| SC 13G | 1999 SCHEDULE 13G - HYSEQ INC | 0000354204-00-000689 | Feb 3, 2000 | — |
| SC 13G | INITIAL 13G FILING | 0000837581-00-000046 | Jan 28, 2000 | — |
| SC 13G | SCHEDULE 13G | 0000891618-98-000739 | Feb 17, 1998 | — |
| SC 13G | SCHEDULE 13G | 0000891618-98-000732 | Feb 17, 1998 | — |
| SC 13G | SCHEDULE 13G | 0000891618-98-000735 | Feb 17, 1998 | — |
| SC 13G | SCHEDULE 13G | 0000891618-98-000804 | Feb 17, 1998 | — |
| SC 13G | — | 0000891547-98-000056 | Jan 28, 1998 | — |